Granules gets American drug regulator's nod for diabetes management drug Metformin
Posted by
www.biotecnika.org
The US Food and Drug Administration (USFDA) has granted final approval
for the company's abbreviated new drug application (ANDA) for
Metformin Hydrochloride extended-release tablets USP, 500 mg and 1000
mg, Granules said in a regulatory filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-gets-american-drug-regulators-nod-for-diabetes-management-drug-metformin/articleshow/80246744.cms
Subscribe to:
Post Comments (Atom)
Post a Comment